Double Wood S-Acetyl L-Glutathione is the best-value way to try the acetylated form — the third distinct answer to glutathione's absorption problem. Where plain reduced GSH is cheap but poorly-absorbed and liposomal physically encapsulates the molecule, S-acetyl bolts on an acetyl group engineered to survive digestion and be cleaved off inside the cell. Double Wood delivers it single-ingredient, purity-tested, and New-York-made at a friendly price. We rank by form first, and S-acetyl earns real credit for a genuinely distinct, sensible mechanism. But honesty requires the caveat that drops it below the liposomal picks: S-acetyl's own human OUTCOME evidence is thin and largely mechanistic — it's a well-reasoned approach rather than a proven one, where liposomal at least has Sinha 2018 behind it. Add a low 100 mg elemental dose with no established S-acetyl dose-response, and this becomes a 'consider,' not an automatic buy. Here's the full breakdown.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Glutathione guide →A genuinely distinct, well-reasoned mechanism: the acetyl group is engineered to protect glutathione through the gut and be cleaved intracellularly — a third route alongside plain reduced and liposomal. Scores well on novelty and rationale, but held below the liposomals because S-acetyl's HUMAN outcome evidence is thin and mechanistic, where liposomal has Sinha 2018.
100 mg is a low elemental dose, and unlike plain GSH (250-1000 mg/day in Richie 2015) S-acetyl has no well-established human dose-response to validate it. Scored as reasonable-by-convention (the form is dosed lower on the survival premise) but not trial-anchored — the lower elemental milligrams are a real, honest limitation.
Made in New York, purity-tested, single-ingredient, non-GMO and gluten-free — solid for the value tier. Held mid-pack because S-acetyl isn't a named branded raw material (less source provenance to verify than the Setria picks) and there's no third-party NSF/USP seal.
At ~$0.47 per capsule it's strong value for S-acetyl, which is a pricier raw material per milligram than commodity reduced glutathione. Within the acetylated tier it's the affordable choice. Cheaper than the liposomals per day, dearer than a bulk plain capsule.
One small single-ingredient capsule a day — effortless to take and stay consistent with over the long haul a glutathione protocol requires. No timing demands, no two-softgel routine, no liquid ritual. The easiest daily fit in the lineup alongside the plain capsules.
“S-acetyl glutathione is more absorbable than standard and liposomal glutathione.”
This is a common marketing claim we can't verify. The acetylated mechanism is a reasonable absorption strategy, but there's no head-to-head human OUTCOME data showing it beats liposomal — which is the form that actually has a human trial (Sinha 2018, PMID 28853742). 'More absorbable than liposomal' is unproven; treat it as a hypothesis, not a fact.
“100 mg of S-Acetyl L-glutathione per capsule.”
The 100 mg per-capsule S-acetyl dose is as stated. Accurate — with the honest context that it's a low elemental dose and S-acetyl lacks an established human dose-response to benchmark against.
“The acetyl group survives the gut and improves cellular uptake.”
Mechanistically reasonable and the explicit design rationale for the form — the acetyl modification is intended to protect the molecule through digestion and release glutathione inside the cell. 'Partial' because this is a designed/proposed mechanism supported more by chemistry than by robust human outcome trials.
“Made in New York and tested for purity; non-GMO and gluten-free.”
Double Wood states US (New York) manufacture, purity testing, non-GMO and gluten-free status — verifiable quality signals appropriate to the value tier, and the main trust markers here given there's no named branded source or NSF/USP seal.
“Supports antioxidant defenses and detoxification.”
Glutathione's antioxidant and phase-II detox roles are established biology, so IF the S-acetyl form delivers glutathione intracellularly as designed, the support rationale follows. 'Partial' because the 'if' — meaningful human delivery and outcomes for S-acetyl specifically — isn't firmly established.
It would be unfair to lump S-acetyl in with plain reduced glutathione. The acetyl group is a genuine chemical approach to the absorption problem: shield the tripeptide through the gut, then let cellular enzymes cleave it to release glutathione inside the cell. That's mechanistically distinct from both plain GSH (which the gut degrades) and liposomal (which encapsulates physically). For the buyer who finds that chemistry compelling, S-acetyl is a legitimate third option, and Double Wood is the affordable way in.
Here's what keeps this a 'consider': S-acetyl's case is largely mechanistic. Unlike liposomal glutathione, which has a human trial behind it (Sinha 2018 raised body stores and immune markers), S-acetyl lacks comparably robust human OUTCOME data — and we won't cite a trial we can't verify. So the appealing mechanism hasn't been matched by the same level of proof in people. If your decision rests on evidence strength, liposomal is the better-supported delivery form; S-acetyl is the better story, not the better-proven one.
Two honest dose points. First, 100 mg is a low elemental amount next to the 500 mg plain capsules — and while the forms aren't 1:1, that gap is real. Second, plain GSH has a human dose range to aim at (250-1000 mg/day, Richie 2015); S-acetyl does not, so there's no trial-validated target to say 100 mg is 'right.' It's a reasonable-by-convention dose, not an evidence-anchored one. Don't assume one 100 mg S-acetyl cap equals a 500 mg plain capsule's worth of effect.
Where it clearly wins: S-acetyl is a pricier raw material per milligram than commodity reduced glutathione, and Double Wood delivers it at about $0.47 a capsule — good value for the form. It's also single-ingredient and one small capsule a day, which makes it effortless to stay consistent with over the months any glutathione protocol needs. If you've decided on S-acetyl, this is the rational pick within the form; the question is whether S-acetyl itself is the form you want.
Double Wood S-Acetyl L-Glutathione is the pick for the buyer specifically drawn to the acetylated form. It's a real, distinct strategy — an acetyl group engineered to carry glutathione past the gut and release it inside the cell — delivered single-ingredient, purity-tested, US-made, and at the best value in its tier. If S-acetyl is the form you want, this is the one to buy. Why it's a 'consider' rather than a clear 'buy' comes down to evidence and dose. S-acetyl's human OUTCOME data is thin and mostly mechanistic, where liposomal glutathione at least has a human trial behind it (Sinha 2018) — so the appealing chemistry isn't yet matched by proof in people, and 'more absorbable than liposomal' is an unverified claim. The 100 mg dose is also low and unanchored, with no established S-acetyl dose-response. If you value evidence strength, the liposomal picks (#2, #3) are better-supported, the named-Setria plain capsule (#1) gives a full trial-range dose for less, and NAC is the cheaper precursor route. Try S-acetyl if its mechanism genuinely appeals — just go in with realistic, evidence-honest expectations.
Check Double Wood Supplements · S-Acetyl L-glutathione (acetylated), 100 mg · 60 capsules on AmazonThe better-evidenced delivery form — Setria in a liposomal complex with an actual human trial behind the category (Sinha 2018). Choose it if evidence strength matters more than the acetylated mechanism.
See it on the list →A full trial-range 500 mg dose of named Setria, for less per day. The pick if you'd rather have a proven dose range and named source than a novel form.
See it on the list →Liposomal delivery at a full 500 mg per serving and the best liposomal value — a stronger-evidenced way to address absorption than S-acetyl.
See it on the list →A single 3 g oral dose of plain glutathione did not raise plasma GSH — 'negligible' availability. The gut-stability problem that S-acetyl's acetyl modification is engineered to overcome.
Liposomal glutathione raised body stores and immune markers in humans — cited as the contrast: the rival delivery form HAS a human outcome trial, whereas S-acetyl's outcome evidence is thin.
250-1000 mg/day plain oral glutathione raised body stores over 6 months — the established human dose range that plain GSH has and S-acetyl lacks, context for why 100 mg S-acetyl is unanchored.
One free quiz · personalized AI Coach path · 4 missions this week. Build your character, build your life.
